Safety evaluation of the food enzyme α-amylase from the genetically modified Bacillus licheniformis strain DP-Dzb52

被引:2
作者
Lambre, Claude
Barat Baviera, Jose Manuel
Bolognesi, Claudia
Cocconcelli, Pier Sandro
Crebelli, Riccardo
Gott, David Michael
Grob, Konrad
Lampi, Evgenia
Mengelers, Marcel
Mortensen, Alicja
Riviere, Gilles
Steffensen, Inger-Lise
Tlustos, Christina
van Loveren, Henk
Vernis, Laurence
Zorn, Holger
Karenlampi, Sirpa
Penninks, Andre
Andryszkiewicz, Magdalena
Gomes, Ana
Kovalkovicova, Natalia
Liu, Yi
Maia, Joaquim
Engel, Karl-Heinz
Chesson, Andrew
机构
关键词
food enzyme; alpha-amylase; 1,4-alpha-D-glucan glucanohydrolase; EC; 3.2.1.1; glycogenase; Bacillus licheniformis; genetically modified microorganism; ASPERGILLUS-DERIVED ENZYMES; ALLERGY; RESPONSES; BREAD;
D O I
10.2903/j.efsa.2021.6564
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The food enzyme alpha-amylase (1,4-alpha-D-glucan glucanohydrolase; EC 3.2.1.1) is produced with the genetically modified Bacillus licheniformis strain DP-Dzb52 by Danisco US Inc. The production strain contains multiple copies of an antimicrobial resistance gene. However, based on the absence of viable cells and DNA from the production organism in the food enzyme, this is not considered to be a risk. The alpha-amylase is intended to be used in starch processing for the production of glucose syrups, brewing processes and distilled alcohol production. Since residual amounts of the food enzyme are removed by the purification steps applied during the production of glucose syrups and distillation, no dietary exposure was calculated. Based on the maximum use levels recommended for the brewing processes and individual data from the EFSA Comprehensive European Food Consumption Database, dietary exposure to the enzyme-total organic solids (TOS) was estimated to be up to 0.145 TOS/kg body weight per day in European populations. The toxicity studies were carried out with another alpha-amylase from B. licheniformis strain DP-Dzb54, considered by the Panel as a suitable substitute. Toxicological tests indicated that there was no concern with respect to genotoxicity or systemic toxicity. A no observed adverse effect level was identified in rats which, compared with the dietary exposure, results in a margin of exposure of at least 750. A search for similarity of the amino acid sequence to known allergens was made and one match was found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions can be excluded in distilled alcohol production and is considered low when the enzyme is used in starch processing and brewing. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use. (C) 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
引用
收藏
页数:17
相关论文
共 23 条
  • [1] Guidance of the Scientific Panel of Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) on the Submission of a Dossier on Food Enzymes for Safety Evaluation by the Scientific Panel of Food Contact Material, Enzymes, Flavourings and Processing Aids
    Anadon, Arturo
    Bell, David
    Binderup, Mona-Lise
    Bursch, Wilfried
    Castle, Laurence
    Crebelli, Riccardo
    Engel, Karl-Heinz
    Franz, Roland
    Gontard, Nathalie
    Haertle, Thomas
    Husoy, Trine
    Jany, Klaus-Dieter
    Leclercq, Catherine
    Lhuguenot, Jean-Claude
    Mennes, Wim C.
    Milana, Maria Rosaria
    Pfaff, Karla
    Svensson, Kettil
    Toldra, Fidel
    Waring, Rosemary
    Woelfle, Detlef
    [J]. EFSA JOURNAL, 2009, 7 (08)
  • [2] Scientific Opinion on the assessment of allergenicity of GM plants and microorganisms and derived food and feed EFSA Panel on Genetically Modified Organisms (GMO Panel)
    Andersson, Hans Christer
    Arpaia, Salvatore
    Bartsch, Detlef
    Casacuberta, Josep
    Davies, Howard
    du Jardin, Patrick
    Flachowsky, Gerhard
    Herman, Lieve
    Jones, Huw
    Karenlampi, Sirpa
    Kiss, Jozsef
    Kleter, Gijs
    Kuiper, Harry
    Messean, Antoine
    Nielsen, Kaare Magne
    Perry, Joe
    Poeting, Annette
    Sweet, Jeremy
    Tebbe, Christoph
    von Wright, Atte Johannes
    Wal, Jean-Michel
    [J]. EFSA JOURNAL, 2010, 8 (07)
  • [3] [Anonymous], EFSA J
  • [4] [Anonymous], 1998, 4 HLTH EFFECTS TEST
  • [5] [Anonymous], 1997, 4 HLTH EFFECTS TEST
  • [6] Why can patients with baker's asthma tolerate wheat flour ingestion? Is wheat pollen allergy relevant?
    Armentia, A.
    Diaz-Perales, A.
    Castrodeza, J.
    Duenas-Laita, A.
    Palacin, A.
    Fernandez, S.
    [J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2009, 37 (04) : 203 - 204
  • [7] Guidance of the Scientific Committee on a request from EFSA related to Uncertainties in Dietary Exposure Assessment Request No EFSA-Q-2004-019 Adopted on 14 December 2006
    Barlow, Sue
    Chesson, Andrew
    Collins, John
    Dybing, Erik
    Flynn, Albert
    Fruijtier-Polloth, Claudia
    Hardy, Tony
    Knaap, Ada
    Kuiper, Harry
    Le Neindre, Pierre
    Schans, Jan
    Schlatter, Josef
    Silano, Vittorio
    Skerving, Steffan
    Vannier, Philippe
    [J]. EFSA JOURNAL, 2007, 5 (01)
  • [8] Guidance on Safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements
    Barlow, Susan
    Chesson, Andrew
    Collins, John D.
    Flynn, Albert
    Galli, Corrado L.
    Hardy, Anthony
    Jany, Klaus-Dieter
    Jeger, Michael-John
    Knaap, Ada
    Kuiper, Harry
    Larsen, John-Christian
    Lovell, David
    Schlatter, Josef
    Silano, Vittorio
    Smulders, Frans
    Vannier, Philippe
    [J]. EFSA JOURNAL, 2009, 7 (09)
  • [9] ALLERGIC REACTION AFTER EATING ALPHA-AMYLASE (ASP-O-2)-CONTAINING BREAD
    BAUR, X
    CZUPPON, AB
    [J]. ALLERGY, 1995, 50 (01) : 85 - 87
  • [10] BRISMAN J, 1991, BRIT J IND MED, V48, P604